Ads
related to: beta blockers for cardiomyopathy- Resources For HCPs
Access Latest Research And Data
On GDMT Therapies.
- Download The Pocket Guide
Download AHA Guidelines
For Quick Reference.
- Access Clinical Tools
Access Tools For Efficient Patient
Management And Record-Keeping.
- View Peer Videos
Explore In-Depth Case Studies
Presented By Fellow Physicians.
- Resources For HCPs
Search results
Results From The WOW.Com Content Network
Beta blocker. Skeletal formula of propranolol, the first clinically successful beta blocker. Beta blockers, also spelled β-blockers, are a class of medications that are predominantly used to manage abnormal heart rhythms (arrhythmia), and to protect the heart from a second heart attack after a first heart attack (secondary prevention). [1]
Beta blockers are used in both cases, but treatment with diuretics, a mainstay of CHF treatment, will exacerbate symptoms in hypertrophic obstructive cardiomyopathy by decreasing ventricular preload volume and thereby increasing outflow resistance (less blood to push aside the thickened obstructing tissue).
Tachycardia-induced cardiomyopathy (TIC) is a disease where prolonged tachycardia (a fast heart rate) or arrhythmia (an irregular heart rhythm) causes an impairment of the myocardium (heart muscle), which can result in heart failure. [1][5] People with TIC may have symptoms associated with heart failure (e.g. shortness of breath or ankle ...
Five-year survival rate ~50% [9] Frequency. 1 in 2500 [9] Dilated cardiomyopathy (DCM) is a condition in which the heart becomes enlarged and cannot pump blood effectively. [3] Symptoms vary from none to feeling tired, leg swelling, and shortness of breath. [2] It may also result in chest pain or fainting. [2]
Arrhythmogenic cardiomyopathy (ACM) is an inherited heart disease. [ 1 ] ACM is caused by genetic defects of parts of the cardiac muscle known as desmosomes, areas on the surface of muscle cells which link them together. The desmosomes are composed of several proteins, and many of those proteins can have harmful mutations.
According to the Hypertrophic Cardiomyopathy Association, HCM is the most common genetic heart condition, affecting at least 1 in every 500 adults—possibly more, given that as many as half of ...
Ad
related to: beta blockers for cardiomyopathy